DADC
IMGN

D.A. Davidson & Co’s Immunogen Inc IMGN Stock Holding History

D.A. Davidson & Co’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-79,406
Closed -$215K – 1170
2019
Q1 		$215K Sell
79,406
-386
-0.5% -$1.67K ﹤0.01% 1020
2018
Q4 		$383K Sell
79,792
-2,649
-3% -$16.1K 0.01% 731
2018
Q3 		$781K Sell
82,441
-3,792
-4% -$36.5K 0.01% 578
2018
Q2 		$839K Sell
86,233
-3,197
-4% -$33.7K 0.02% 548
2018
Q1 		$941K Sell
89,430
-3,919
-4% -$38.7K 0.02% 484
2017
Q4 		$598K Sell
93,349
-1,216
-1% -$7.5K 0.01% 613
2017
Q3 		$723K Buy
94,565
+214
+0.2% +$1.42K 0.01% 580
2017
Q2 		$670K Sell
94,351
-11,339
-11% -$51.9K 0.02% 541
2017
Q1 		$409K Buy
105,690
+622
+0.6% +$1.81K 0.01% 676
2016
Q4 		$213K Sell
105,068
-1,906
-2% -$3.83K ﹤0.01% 976
2016
Q3 		$285K Buy
106,974
+30,415
+40% +$88.4K 0.01% 812
2016
Q2 		$235K Buy
76,559
+2,884
+4% +$18.1K 0.01% 785
2016
Q1 		$627K Buy
73,675
+1,004
+1% +$8.49K 0.02% 476
2015
Q4 		$985K Sell
72,671
-14
-0% -$172 0.03% 403
2015
Q3 		$697K Buy
72,685
+573
+0.8% +$8.38K 0.02% 454
2015
Q2 		$1.04M Sell
72,112
-21,035
-23% -$231K 0.03% 400
2015
Q1 		$833K Buy
93,147
+18,177
+24% +$132K 0.03% 448
2014
Q4 		$456K Buy
74,970
+15,037
+25% +$138K 0.01% 595
2014
Q3 		$634K Buy
59,933
+8,419
+16% +$95.2K 0.02% 527
2014
Q2 		$608K Buy
51,514
+15,649
+44% +$196K 0.02% 541
2014
Q1 		$533K Buy
35,865
+6,691
+23% +$105K 0.02% 585
2013
Q4 		$426K Buy
29,174
+2,405
+9% +$37K 0.02% 632
2013
Q3 		$455K Buy
26,769
+1,602
+6% +$28.2K 0.02% 522
2013
Q2 		$415K Buy
+25,167
New +$408K 0.02% 523

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.A. Davidson & Co's IMGN Position: Q2 2019 in Review

D.A. Davidson & Co sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 79,406 shares — an estimated $215K sold.

D.A. Davidson & Co first reported a position in IMGN in Q2 2013 and held it in 24 quarters. The position peaked at $1.04M in Q2 2015. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

  • D.A. Davidson & Co reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
  • D.A. Davidson & Co sold 79,406 Immunogen Inc shares in Q2 2019, an estimated $215K.
  • D.A. Davidson & Co first reported a position in Immunogen Inc in Q2 2013 and held it in 24 quarters.
  • D.A. Davidson & Co's Immunogen Inc position peaked at $1.04M in Q2 2015.
  • 192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on D.A. Davidson & Co's 13F filing for Q2 2019, filed 13 Aug 2019.